AMAM News and Press, Ambrx Biopharma Inc. American Depositary Shares (each representing seven) From 01/25/24

NEW YORK, NY / ACCESSWIRE / January 25, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Callon Petrol...

2024-01-22 12:21:31 ET More on Johnson & Johnson Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off? Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuits And Ambrx Acquisition Johnson & Johnson: $2 Billion Buyout Of Antibody...

NEW YORK, NY / ACCESSWIRE / January 20, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Axonics, Inc. (NASDAQ:AXNX)'s sa...

NEW YORK, NY / ACCESSWIRE / January 17, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Karuna Therapeutics, Inc. (NASDAQ:...

2024-01-14 03:40:00 ET Summary Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2 billion. San Diego’s Ambrx Biopharma will be acquired by Johnson & Johnson for $2 billion. GSK plans to acquire Aiolos Bio, a San Francisco-London s...

2024-01-10 23:19:52 ET Summary Ambrx Biopharma is a biotech company with an advanced approach to antibody-drug conjugates (ADCs) for oncology. Their proprietary platform for expanded genetic code technology creates ADCs for prostate and breast cancer treatment. The recent acqu...

NEW YORK, NY / ACCESSWIRE / January 10, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Juniper Networks, Inc. (NYSE:JNPR)...

NEW YORK, NY / ACCESSWIRE / January 10, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Harpoon Therapeutics, Inc. (NASDAQ...

PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the number of Americans aged 65 and older is projected to increase more than double over...

2024-01-09 06:00:00 ET Summary Johnson & Johnson has announced plans to acquire Ambrx, a clinical-stage biopharmaceutical company specializing in antibody drug conjugates (ADCs), for ~$2.0 billion. ADCs have become a popular investment for big pharma companies, with Pfizer, Ab...